64
intensive care unit: a multicenter study. Critical care. 2012;16(4):R155. 2. File TM. Community-acquired pneumonia. Lancet. 2003; 362:1991
3. Centers for Disease Control and Prevention. FastStats : Pneumonia(Internet).2013(updated 2013 April 5; cited 2014 Januari 10).Available from : www.cdc.gov/nchs/fastats/pneumonia.htm
4. Ewig, S., Birkner, N., Strauss, R., Schaefer, E., Pauletzki, J., Bischoff, H. et al. New perspectives on community-acquired pneumonia in 388406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality.Thorax.2009; 64: 1062–1069
5. Navdeep K. Brar M, Michael S. Niederman, MD. Management of community-acquired Pneumonia. Therapeutic Advances in Respiratory Disease. 2011;5(1):61 - 78.Available from : www.medscape.com
6. Pokja Infeksi Perhimpunan Dokter Paru Indonesia.Pneumonia Komunitas : Pedoman Diagnosis dan Penatalaksanaan Di Indonesia.2003
7. Mandell LA, Wunderink RG, Anzueto A, Bartlett JG, Campbell GD, Dean NC, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults. Clinical infectious diseases. 2007;44(Supplement 2):S27-S72. 8. Ho P-L, Cheng VC-C, Chu C-M. Antibiotic resistance in community-acquired
pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii. CHEST Journal. 2009;136(4):1119-27.
10.Arancibia F, Ewig S, Martinez JA, Ruiz M, Bauer T, Marcos MA, et al. Antimicrobial treatment failures in patients with community-acquired pneumonia: causes and prognostic implications. American journal of respiratory and critical care medicine. 2000;162(1):154-60.
11.Fine MJ, Pratt HM, Obrosky DS, Lave JR, McIntosh LJ, Singer DE, et al. Relation between length of hospital stay and costs of care for patients with community-acquired pneumonia. The American journal of medicine. 2000;109(5):378-85.
12.Bartolome M, Almirall J, Morera J, Pera G, Ortun V, Bassa J, et al. A population-based study of the costs of care for community-acquired pneumonia. European Respiratory Journal. 2004;23(4):610-6.
13.Kementerian Kesehatan Republik Indonesia.Triple Burden Ancam Lansia.Jakarta : Pusat Komunikasi Publik Sekretariat Jenderal Kementerian Kesehatan RI;2013.Available from : www.depkes.go.id
14.Sato R, Rey GG, Nelson S, Pinsky B. Community-acquired pneumonia episode costs by age and risk in commercially insured US adults aged≥ 50 years. Applied health economics and health policy. 2013;11(3):251-8.
15.Dahlan Z. Pneumonia.Buku Ajar Ilmu Penyakit Dalam. 2. 4 ed. In: W.Sudoyo A, Setiyohadi B, Alwi I, K. MS, Setiati S, editors. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Indonesia; 2006. p. 964 - 71.
16.Cascini S AN, Incalzi RA, Pinnarelli L, Mayer F, Arcà M, Fusco D, Davoli M. Pneumonia burden in elderly patients: a classification algorithm using administrative data. BMC Infectious Disease. 2013;13(559).
18.Armitage K, Woodhead M. New guidelines for the management of adult community-acquired pneumonia. Current opinion in infectious diseases. 2007;20(2):170-6.
19.Gutierrez F, Masia M, Rodriguez J, Mirete C, Soldan B, Padilla S, et al. Epidemiology of community‐acquired pneumonia in adult patients at the dawn of the 21st century: a prospective study on the Mediterranean coast of Spain. Clinical microbiology and infection. 2005;11(10):788-800.
20.American Lung Association(Internet).Chicago : Understanding Pneumonia;c2014(cited 2014 Januari 10).Available from : www.lung.org/lung-disease/pneumonia/understanding-pneumonia.html
21.Tsai-Ling Lauderdale F-YC, Ren-Jy Ben, Hsiao-Chuan Yin, et al. Etiology of community acquired pneumonia among adult patients requiring hospitalization in Taiwan. Respiratory Medicine. 2005(99):1079 - 86.
22.Almirall J, Bolibar I, Vidal J, Sauca G, Coll P, Niklasson B, et al. Epidemiology of community-acquired pneumonia in adults: a population-based study. European Respiratory Journal. 2000;15(4):757-63.
23.Cunha, A Burke.Community Acquired Pneumonia(Internet);2014(last updated 2014 Januari 13, cited 2014 Januari 5).Available from : www.emedicine.medscape.com/article/234240-overview#aw2aab6b4
24.National Health Service(Internet).United Kingdom : Pneumonia – Causes;2012 (last reviewed 2012 Juni 15, cited 2013 23 Desember 2013).Available from : www.nhs.uk/conditions/pneumonia/pages/causes.aspx 25.ZS, Priyanti.Bagian Pulmonologi FK UI/RSUP Persahabatan Jakarta :
Konsensus Pneumonia(Internet); c2014 (cited 2014 Januari 5).Available from : www.klikpdpi.com/konsensus/Xsip/konsensus-pneumonia/pneumonia.htm 26.Khalil MM, Abdel Dayem AM, Farghaly AAA-H, Shehata HM. Pattern of
27.Woodhead M. Community-acquired pneumonia in Europe: causative pathogens and resistance patterns. European Respiratory Journal. 2002;20(36 suppl):20s-7s.
28.A.Mandell L, Wunderink R. Pneumonia. Harrison's Principles of Internal Medicine. 2. 18th Edition ed. Jakarta: Penerbit Buku Kedokteran EGC.2006.957 – 90 p.
29.Sylvia A.Price LMW. Patofisiologi : Konsep Klinis Proses - Proses Penyakit. In: dr.Huriawati Hartanto dNS, dr.Pita Wulansari,dr.Dewi Asih Mahanani, editor. 2. Jakarta: Penerbit Buku Kedokteran EGC.2002. p. 804 - 10.
30.Lynch JP, Zhanel GG. Streptococcus pneumoniae: Epidemiology, Risk Factors, and Strategies for Prevention. Seminars in Respiratory and Critical Care Medicine Thieme Medical Publishers 2009. p. 189-209
31.Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J, et al. Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity. American Journal of Respiratory and Critical Care Medicine. 1999;160(2):397-405.
32.F.Simonetti A, Viasus D, Garcia-Vidal C, Carratala J. Management of community-acquired pneumonia in older adults. Therapeutic Advances in Infectious Disease. 2014;2(1):3- 16.
33.Fine MJ, Stone RA, Singer DE, Coley CM, Marrie TJ, Lave JR, et al. Processes and outcomes of care for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team (PORT) cohort study. Archives of internal medicine. 1999;159(9):970-80. 34.Sharma Sat, Maycher Bruce, Eschun Gregg.Radiological Imaging in
35.Boersma WG, Daniels J, Löwenberg A, Boeve W-J, van de Jagt EJ. Reliability of radiographic findings and the relation to etiologic agents in community-acquired pneumonia. Respiratory medicine. 2006;100(5):926-32. 36.Schmitt, Steven. Cleveland : Community Acquired Pneumonia(Internet);
c2014 (cited 2014 Januari 5).Available from : www.clevelandclinicmed.com/medicalpubs/diseasemanagement/infectious-disease/community-acquired-pneumonia/#bib10
37.Van der Eerden M, Vlaspolder F, De Graaff C, Groot T, Bronsveld W, Jansen H, et al. Comparison between pathogen directed antibiotic treatment and empirical broad spectrum antibiotic treatment in patients with community acquired pneumonia: a prospective randomised study. Thorax. 2005;60(8):672-8.
38.Snijders D, Daniels JM, de Graaff CS, van der Werf TS, Boersma WG. Efficacy of corticosteroids in community-acquired pneumonia: a randomized double-blinded clinical trial. Am J Respir Crit Care Med. 2010;181(9):975– 982.
39.Blasi F, Garau J, Medina J, Ávila M, McBride K, Ostermann H. Current management of patients hospitalized with community-acquired pneumonia across Europe: outcomes from REACH. Respir Res. 2013;14:44
40.Oosterheert JJ, Bonten MJ, Schneider MM, et al. Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial. BMJ. 2006;333(7580):1193.
41.Carratalà J, Garcia-Vidal C, Ortega L, Fernández-Sabé N, Clemente M, Albero G, et al. Effect of a 3-step critical pathway to reduce duration of intravenous antibiotic therapy and length of stay in community-acquired pneumonia: a randomized controlled trial. Archives of internal medicine. 2012;172(12):922-8.
adult patients in Asian countries: a prospective study by the Asian network for surveillance of resistant pathogens. International Journal of Antimicrobial Agents(Internet). 2008 (cited 2013 Desember 20); 31(2):107–14.Available from : www.sciencedirect.com/science/article/pii/S0924857907004888
43.Mortensen EM, Coley CM, Singer DE, Marrie TJ, Obrosky DS, Kapoor WN, et al. Causes of death for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team cohort study. Archives of Internal Medicine. 2002;162(9):1059-64.
44.Kikuchi, Ryo, et al. High incidence of silent aspiration in elderly patients with community-acquired pneumonia. American Journal of Respiratory and Critical Care Medicine. 1994; 150(1): 251-253.
45.Fung, Horatio B.; Monteaguda-Chu, Maricelle O. Community-acquired pneumonia in the elderly. The American journal of geriatric pharmacotherapy. 2010; 8(1): 47-62.
46.Kaplan, V., Angus, D. C., Griffin, M. F., Clermont, G., Scott Watson, R. & Linde – Zwirble, W.T.Hospitalized community-acquired pneumonia in the elderly: age-and sex-related patterns of care and outcome in the United States. American journal of respiratory and critical care medicine.2002;165 : 766-772.
47.Torres, A., Peetermans, W. E., Viegi, G., & Blasi, F. Risk factors for community-acquired pneumonia in adults in Europe: a literature review. Thorax. 2013; 68(11) : 1057-1065.
48.Corrales-Medina, V. F., Musher, D. M., Shachkina, S., & Chirinos, J. A.Acute pneumonia and the cardiovascular system. The Lancet.2013; 381(9865) : 496-505.
50.Saibal, M. A. A., Rahman, S. H. Z., Nishat, L., Sikder, N. H., Begum, S. A., Islam, M. J., & Uddin, K. N. Community acquired pneumonia in diabetic and non-diabetic hospitalized patients: presentation, causative pathogens and outcome. Bangladesh Medical Research Council Bulletin. 2013; 38(3) : 98-103.
51.Bansal, S., Kashyap, S., Pal, L. S., & Goel, A.Clinical and bacteriological profile of community acquired pneumonia in Shimla, Himachal Pradesh. Indian Journal of Chest Diseases and Allied Sciences.2004; 46(1) : 17-22. 52.Furer, V., Raveh, D., Picard, E., Goldberg, S., & Izbicki, G.Absence of
leukocytosis in bacteraemic pneumococcal pneumonia. Prim Care Respir J. 2011; 20(3) : 276-281.
53.Khalil, M. M., Abdel Dayem, A. M., Farghaly, A. A. A. H., & Shehata, H. M. Pattern of community and hospital acquired pneumonia in Egyptian military hospitals. Egyptian Journal of Chest Diseases and Tuberculosis.2013; 62(1) : 9-16.
54.Kolditz, M., Halank, M., & Höffken, G. 2006. Monotherapy versus combination therapy in patients hospitalized with community-acquired pneumonia. Treatments in respiratory medicine. 2006; 5(6) : 371-383. 55.Nair, G. B., & Niederman, M. S. Community-acquired pneumonia: an
Lampiran 3
Biodata Mahasiswa Identitas
Nama : Nur Muhamad Arjanardi
NIM : 22010110120064
Tempat tanggal lahir : Kabupaten Semarang, 27 September 1992 Jenis Kelamin : Laki-laki
Alamat : Jl. Parasamya IV-94, perumda, Ungaran
No. HP : 085726838946
Email : nurmuhamad30@gmail.com Riwayat Pendidikan Formal :
1. SD : SDN UNGARAN 1 Lulus tahun: 2004 2. SMP : SMP N 1 UNGARAN Lulus tahun: 2007 3. SMA : SMA TARUNA NUSANTARA Lulus tahun: 2010 4. SI : Fakultas Kedokteran Universitas Diponegoro Masuk : 2010 Riwayat Organisasi
1. HIMA KU UNDIP
